Your browser doesn't support javascript.
loading
Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Takahashi, Masato; Cortés, Javier; Dent, Rebecca; Pusztai, Lajos; McArthur, Heather; Kümmel, Sherko; Denkert, Carsten; Park, Yeon Hee; Im, Seock-Ah; Ahn, Jin-Hee; Mukai, Hirofumi; Huang, Chiun-Sheng; Chen, Shin-Cheh; Kim, Min Hwan; Jia, Liyi; Li, Xin Tong; Tryfonidis, Konstantinos; Karantza, Vassiliki; Iwata, Hiroji; Schmid, Peter.
Affiliation
  • Takahashi M; Department of Breast Surgery, Hokkaido University Hospital, Sapporo, Japan.
  • Cortés J; International Breast Cancer Center, Pangaea Oncology, Quironsalud Group, Barcelona, Spain.
  • Dent R; Medical Scientia Innovation Research (MEDSIR), Barcelona, Spain.
  • Pusztai L; Faculty of Biomedical and Health Sciences, Department of Medicine, Universidad Europea de Madrid, Madrid, Spain.
  • McArthur H; National Cancer Center Singapore, Duke-NUS Medical School, Singapore.
  • Kümmel S; Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut.
  • Denkert C; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas.
  • Park YH; Breast Unit, Department of Gynecology with Breast Center, Kliniken Essen-Mitte, Essen, Germany.
  • Im SA; Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Ahn JH; Institute of Pathology, Philipps-University Marburg and University Hospital Marburg (UKGM), Marburg, Germany.
  • Mukai H; Hematology-Oncology, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Huang CS; Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • Chen SC; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Kim MH; National Cancer Center Hospital East, Kashiwa-shi, Japan.
  • Jia L; National Taiwan University Hospital, Taipei, Taiwan.
  • Li XT; Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Tryfonidis K; Yonsei University College of Medicine, Seoul, Korea.
  • Karantza V; Merck & Co Inc, Rahway, New Jersey.
  • Iwata H; Merck & Co Inc, Rahway, New Jersey.
  • Schmid P; Merck & Co Inc, Rahway, New Jersey.
JAMA Netw Open ; 6(11): e2342107, 2023 Nov 01.
Article in En | MEDLINE | ID: mdl-37966841
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triple Negative Breast Neoplasms Limits: Adult / Female / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: JAMA Netw Open Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triple Negative Breast Neoplasms Limits: Adult / Female / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: JAMA Netw Open Year: 2023 Document type: Article Affiliation country: Country of publication: